HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
HONG KONG, Oct. 18, 2025 /PRNewswire/ — The Hong Kong University of Science and Technology (HKUST) today held its Congregation 2025, conferring Honorary Doctorates... Read more.
Co-Founder of Bridgemans Services Group named EY Entrepreneur Of The Year® 2025 Pacific
Brian Grange recognized for revolutionizing workforce housing through innovative maritime solutions VANCOUVER, BC, Oct. 18, 2025 /CNW/ – | Traditional territory... Read more.
PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive bladder... Read more.
Global Sources Hong Kong Shows Phase II Officially Opens: AI Pavilion Debuts, Spotlighting Latest AI and Robotics Trends
HONG KONG, Oct. 18, 2025 /PRNewswire/ — The second phase of the Global Sources Hong Kong Shows opened today at AsiaWorld-Expo, running from October 18 to... Read more.
MorseLife Named a Fortune Media 2025 Best Workplace in Aging Services
Underscores MorseLife’s exceptional workplace culture and enduring commitment to purpose-driven senior care WEST PALM BEACH, Fla., Oct. 18, 2025 /PRNewswire/... Read more.
Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025
Encouraging preliminary activity observed across diverse set of advanced ALK-positive solid tumors Global enrollment ongoing for adult and adolescent patients with... Read more.
Parental Control App for iPhone (2025): Qustodio Named Leading iPhone Safety App by Expert Consumers
NEW YORK, Oct. 18, 2025 /PRNewswire/ — Expert Consumers has named Qustodio the leading parental control app for iPhone in its 2025 review, citing advanced... Read more.
Florida Cancer Specialists & Research Institute Shaping the Future of Cancer Care at Global Congress
Oral Presentation to be Featured on Initial Results of a First-in-Human Study for a Promising Targeted Therapy for Advanced/Metastatic Solid Tumors. ESMO 2025 abstracts... Read more.
SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025
SINGAPORE, Oct. 18, 2025 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for... Read more.
PRIVACY ALERT: PeopleGuru, Inc. Under Investigation for Data Breach of Records
SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to the sensitive... Read more.